Read + Share
Girard N. In Patients With Early Stage NSCLC Without Driver Mutation After Surgical
Resection and Chemotherapy: Adjuvant Atezolizumab Should Only Be Given for
Patients With Programmed Death-Ligand 1 Greater Than or Equal to 50. J Thorac Oncol 2023;18:268-270.
PMID: 36842811
|
 |
|
